Immunocore Files 2024 10-K
Ticker: IMCR · Form: 10-K · Filed: Feb 26, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | 10-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotechnology, annual-report
TL;DR
IMCR 2024 10-K filed. Full financials and biz details out.
AI Summary
Immunocore Holdings plc filed its 2024 10-K on February 26, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on biological products, operates from Oxfordshire, UK. Key financial data and business segments are detailed within the filing, which covers its operations as a public entity since its name change from Immunocore Ltd in 2016.
Why It Matters
This filing provides a comprehensive overview of Immunocore's financial health, strategic direction, and operational performance for the fiscal year 2024, crucial for investors and stakeholders to assess the company's value and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Immunocore faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 10-K filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-26 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Immunocore Holdings plc (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-26 (date) — Filing date
- Immunocore Ltd (company) — Former company name
- KPMG LLP (company) — Auditor
FAQ
What were Immunocore's total revenues for the fiscal year ended December 31, 2024?
The filing indicates revenue segments such as 'SaleOfTherapiesMember' and 'CollaborationRevenueMember' for the period 2024-01-01 to 2024-12-31, but specific total revenue figures are not provided in this excerpt.
Who is Immunocore's auditor for the fiscal year 2024?
KPMG LLP is listed as the auditor for Immunocore Holdings plc for the period 2024-01-01 to 2024-12-31.
When did Immunocore Holdings plc change its name from Immunocore Ltd?
The date of the name change from Immunocore Ltd to Immunocore Holdings plc was April 12, 2016.
What is Immunocore's primary business classification?
Immunocore Holdings plc is classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
What is the SEC file number for this 10-K filing?
The SEC file number for this 10-K filing is 001-39992.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 26, 2025 regarding Immunocore Holdings plc (IMCR).